Wellbiotec Co. Ltd. (010600) — Capital Reinvestment Ratio
Latest as of September 2024:
0.00x
Wellbiotec Co. Ltd. (010600) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow (₩2.72 Billion) in capital expenditures (₩10.89 Million). See free cash flow generation of Wellbiotec Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.72 Billion
KRW
Capital Expenditures
₩10.89 Million
KRW
Data as of
Sep 2024
Most recent filing
Wellbiotec Co. Ltd. Capital Reinvestment Ratio (2005–2022)
This chart tracks Wellbiotec Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Wellbiotec Co. Ltd. (2005–2022)
Year-by-year Capital Reinvestment Ratio for Wellbiotec Co. Ltd. from 2005 to 2022. For live market cap and broader valuation context, see 010600 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.19x | ₩2.62 Billion | ₩508.76 Million | ▼ -75.6% |
| 2021 | 0.79x | ₩712.97 Million | ₩565.92 Million | ▲ +259.3% |
| 2015 | 0.22x | ₩4.28 Billion | ₩944.92 Million | ▼ -20.8% |
| 2013 | 0.28x | ₩1.01 Billion | ₩281.62 Million | ▲ +3.1% |
| 2012 | 0.27x | ₩3.06 Billion | ₩826.93 Million | ▲ +80.2% |
| 2010 | 0.15x | ₩2.90 Billion | ₩435.67 Million | ▼ -94.0% |
| 2008 | 2.51x | ₩3.11 Billion | ₩7.82 Billion | ▲ +212.3% |
| 2006 | 0.81x | ₩4.49 Billion | ₩3.62 Billion | ▼ -79.2% |
| 2005 | 3.87x | ₩1.48 Billion | ₩5.72 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow